'Personalized medicine': What's in a name?

Personalized Medicine

Volumn 11, Issue 2, 2014, Pages 197-210

  Pokorska Bocci, Anna ^a   Stewart, Alison ^a   Sagoo, Gurdeep S ^a   Hall, Alison ^a   Kroese, Mark ^a   Burton, Hilary ^a  

^a PHG FOUNDATION   (United Kingdom)

Author keywords

genomics; individualized medicine; patient empowerment; personalized medicine; precision medicine; stratified medicine

Indexed keywords

ACCURACY; DISEASE CLASSIFICATION; GENOMICS; MEDICAL CARE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; TECHNOLOGY;

EID: 84899475714     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.13.107     Document Type: Review

References (60)

1. Baker M. Reprogramming Rx. Nat. Med. 17(3), 241-243 (2011
2. Gravitz L. A fight for life that united a field. Nature 478(7368), 163-164 (2011
3. Srivastava P. Drug metabolism and individualized medicine. Curr. Drug Metab. 4(1), 33-44 (2003
4. Committee on a Framework for Development a New Taxonomy of Disease, National Research Council. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. The National Academies Press, DC, USA (2011
5. Wasi P. Human genomics: Implications for health. Southeast Asian J. Trop. Med. Public Health 28(Suppl. 2), 19-24 (1997
6. Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: Strategic and economic implications of combining drugs and clinical biomarkers. Nat. Rev. Drug Discov. 6(4), 287-293 (2007
7. Hood L. A personal journey of discovery: Developing technology and changing biology. Annu. Rev. Anal. Chem. (Palo Alto Calif.) 1, 1-43 (2008
8. Abrahams E, Ginsburg GS, Silver M. The Personalized Medicine Coalition: Goals and strategies. Am. J. Pharmacogenomics 5(6), 345-355 (2005
9. Langreth R, Waldholz M. New era of personalized medicine: Targeting drugs for each unique genetic profile. Oncologist 4(5), 426-427 (1999
10. Teng K, Eng C, Hess CA et al. Building an innovative model for personalized healthcare. Cleve. Clin. J. Med. 79 (Suppl. 1), S1-S9 (2012
11. Abidi SS, Goh A. A personalised healthcare information delivery system: Pushing customised healthcare information over the WWW. Stud. Health Technol. Inform. 77, 663-667 (2000
12. Hall JG. Individualized medicine. What the genetic revolution will bring to health care in the 21st century. Can. Fam. Physician 49, 12-17 (2003
13. Hoffman MA, Williams MS. Electronic medical records and personalized medicine. Hum. Genet. 130(1), 33-39 (2011
14. Graham-Rowe D. Overview: Multiple lines of attack. Nature 480(7377), S34-S35 (2011
15. Humphries C. Genetics: Profiling a shape-shifter. Nature 480(7377), S50-S51 (2011
16. Boguski MS, Arnaout R, Hill C. Customized care 2020: How medical sequencing and network biology will enable personalized medicine. F1000 Biol. Rep. 1, 73 (2009
17. Director's challenge: Toward a molecular classification of tumors (1999). http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-98-027.html
18. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N. Engl. J. Med. 366(6), 489-491 (2012
19. Robinson PN. Deep phenotyping for precision medicine. Hum. Mutat. 33(5), 777-780 (2012
20. Blair ED, Clarke BR, Oneill T. Sustaining development of stratified medicines in the UK healthcare system: A commentary. Pers. Med. 8(5), 517-521 (2011
21. Shaw EC, Johnson PW. Stratified medicine for cancer therapy. Drug Discov.Today 17(5-6), 261-268 (2012
22. Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: Predictive, preventive, personalized and participatory. N. Biotechnol. 29(6), 613-624 (2012
23. Pravettoni G, Gorini A. A P5 cancer medicine approach: Why personalized medicine cannot ignore psychology. J. Eval. Clin. Pract. 17(4), 594-596 (2011
24. Khoury MJ, Gwinn ML, Glasgow RE, Kramer BS. A population approach to precision medicine. Am. J. Prev. Med. 42(6), 639-645 (2012
25. Gibson WM. Can personalized medicine survive? Can. Fam. Physician 17(8), 29-88 (1971
26. Gupta R, Kim J, Spiegel J, Ferguson SM. Developing products for personalized medicine: NIH Research Tools Policy applications. Pers. Med. 1(1), 115-124 (2004
27. Burke W, Psaty BM. Personalized medicine in the era of genomics. JAMA 298(14), 1682-1684 (2007
28. Woodcock J. The prospects for 'personalized medicine' in drug development and drug therapy. Clin. Pharmacol. Ther. 81(2), 164-169 (2007
29. Moon H, Ahn H, Kodell RL, Baek S, Lin CJ, Chen JJ. Ensemble methods for classification of patients for personalized medicine with high-dimensional data. Artif. Intell. Med. 41(3), 197-207 (2007
30. Meyer UA. Personalized medicine: A personal view. Clin. Pharmacol. Ther. 91(3), 373-375 (2012
31. Hong KW, Oh B. Overview of personalized medicine in the disease genomic era. BMB. Rep. 43(10), 643-648 (2010
32. Brand A. Public Health Genomics and personalized healthcare: A pipeline from cell to society. Drug Metabol. Drug Interact. 27(3), 121-123 (2012
33. Carlberg C. The need for education in personalized medicine. Pers. Med. 9(2), 147-150 (2012
34. Moldrup C. Beyond personalized medicine. Pers. Med. 6(3), 231-233 (2009
35. Fierz W. Challenge of personalized health care: To what extent is medicine already individualized and what are the future trends? Med. Sci. Monit. 10(5), RA111-RA123 (2004
36. Personalised Medicine for the European Citizen-Towards More Precise Medicine for the Diagnosis, Treatment. European Science Foundation, Strasbourg, France (2012
37. Harvey A. Opinion leaders' views on issues in personalized medicine. Pers. Med. 9(2), 127-131 (2012
38. Cribb A, Owens J. Whatever suits you: Unpicking personalization for the NHS. J. Eval. Clin. Pract. 16(2), 310-314 (2010
39. Abidi SS, Han CY, Abidi SR. Patient empowerment via 'pushed' delivery of personalised healthcare educational content over the internet. Stud. Health Technol. Inform. 84(Pt 2), 1425-1429 (2001
40. Zhang D, Yu Z, Chin CY. Context-Aware infrastructure for personalized healthcare. Stud. Health Technol. Inform. 117, 154-163 (2005
41. Jang H, Kim S, Bae C. Personalized healthcare through intelligent gadgets. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2008, 3308-3311 (2008
42. Brand A. Integrative genomics, personal-genome tests and personalized healthcare: The future is being built today. Eur. J. Hum. Genet. 17(8), 977-978 (2009
43. Nicholson JK, Holmes E. Global systems biology and personalized healthcare solutions. Discov. Med. 6(32), 63-70 (2006
44. Simmons LA, Dinan MA, Robinson TJ, Snyderman R. Personalized medicine is more than genomic medicine: Confusion over terminology impedes progress towards personalized healthcare. Pers. Med. 9(1), 85-91 (2012
45. Noseworthy PA, Newton-Cheh C. Genetic determinants of sudden cardiac death. Circulation 118(18), 1854-1863 (2008
46. Baird RD, Caldas C Genetic heterogeneity in breast cancer: The road to personalized medicine? BMC Med. 11, 151 (2013
47. Curtis C, Shah SP, Chin SF et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486(7403), 346-352 (2012
48. Phillips EJ, Mallal SA. Pharmacogenetics of drug hypersensitivity. Pharmacogenomics 11(7), 973-987 (2010
49. Leary RJ, Kinde I, Diehl F et al. Development of personalized tumor biomarkers using massively parallel sequencing. Sci. Transl. Med. 2(20), 20ra14 (2010
50. McBride DJ, Orpana AK, Sotiriou C et al. Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors. Genes Chromosomes Cancer 49(11), 1062-1069 (2010
51. Bonham JR. Impact of new screening technologies: Should we screen and does phenotype influence this decision? J. Inherit. Metab. Dis. 36(4), 681-686 (2013
52. Sasinowski FJ. Quantum of Effectiveness Evidence in FDA's Approval of Orphan Drugs. National Organization for Rare Disorders, CT, USA (2011
53. Tang WH. The ongoing search for a stratified medicine approach in heart failure. J. Am. Coll. Cardiol. 51(24), 2310-2312 (2008
54. Burton H, Sagoo GS, Pharoah P, Zimmern RL. Time to revisit Geoffrey Rose: Strategies for prevention in the genomic era? Ital. J. Public Health 9(4), e8665-1-e8665-9 (2012
55. Esserman LJ, Thompson IM, Reid B. Overdiagnosis and overtreatment in cancer: An opportunity for improvement. JAMA 310(8), 797-798 (2013
56. Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P. Public health implications from COGS and potential for risk stratification and screening. Nat. Genet. 45(4), 349-351 (2013
57. PatientsLikeMe®. www.patientslikeme.com
58. Kaye J, Curren L, Anderson N et al. From patients to partners: Participant-centric initiatives in biomedical research. Nat. Rev. Genet. 13(5), 371-376 (2012
59. Medical Profiling and Online Medicine: The Ethics of 'Personalised Healthcare' in a Consumer Age. Nuffield Council on Bioethics, London, UK (2010
60. Larson EB. Building trust in the power of 'big data' research to serve the public good. JAMA 309(23), 2443-2444 (2013